Patients aren’t just participants. They’re partners shaping the future of #digestivehealth. 🤝
🔗 bit.ly/3Xvwo0w
#EUNewsline
Patients aren’t just participants. They’re partners shaping the future of #digestivehealth. 🤝
🔗 bit.ly/3Xvwo0w
#EUNewsline
#PCAM #PancreaticCancer #WorldPancreaticCancerDay #DISCERN @pancan.bsky.social @letswinpc.org @pancreaticcanuk.bsky.social @who.int
#PCAM #PancreaticCancer #WorldPancreaticCancerDay #DISCERN @pancan.bsky.social @letswinpc.org @pancreaticcanuk.bsky.social @who.int
Together, we’ll explore how 🇪🇺 can deliver equitable, effective screening for all at risk.
🗓️ 4 Dec 25, 09:00 CET
💻 Online
🔗 digestivecancers-eu.zoom.us/webinar/regi...
@mepsagainstcancer.bsky.social @nkinl.bsky.social @crcequity.bsky.social
Together, we’ll explore how 🇪🇺 can deliver equitable, effective screening for all at risk.
🗓️ 4 Dec 25, 09:00 CET
💻 Online
🔗 digestivecancers-eu.zoom.us/webinar/regi...
@mepsagainstcancer.bsky.social @nkinl.bsky.social @crcequity.bsky.social
#AMR is not a distant issue; it’s a challenge we face in #CancerCare every day. #WAAW
@stanfordasp.bsky.social @bsacandjac.bsky.social @who.int
#AMR is not a distant issue; it’s a challenge we face in #CancerCare every day. #WAAW
@stanfordasp.bsky.social @bsacandjac.bsky.social @who.int
It often develops slowly, and its early signs are easy to overlook.
Learn more➡️ buff.ly/uxGEV2z
#GCAM
It often develops slowly, and its early signs are easy to overlook.
Learn more➡️ buff.ly/uxGEV2z
#GCAM
⏱️ Takes about 20 minutes, is completely anonymous and is available in 15 different languages.
👉 buff.ly/IT0w5bE
⏱️ Takes about 20 minutes, is completely anonymous and is available in 15 different languages.
👉 buff.ly/IT0w5bE
Did you know you can take action to lower your risk of #PancreaticCancer? 👉https://buff.ly/o4AUmWZ
Did you know you can take action to lower your risk of #PancreaticCancer? 👉https://buff.ly/o4AUmWZ
This year’s summit will bring together leading experts, healthcare professionals, patients and policymakers to advance effective, accessible & sustainable CRC screening programmes.
➡️https://buff.ly/UiAb6AC
This year’s summit will bring together leading experts, healthcare professionals, patients and policymakers to advance effective, accessible & sustainable CRC screening programmes.
➡️https://buff.ly/UiAb6AC
Got an idea to improve screening, treatment, or patient care pathway?👉 or9ieqov0cb.typeform.com/to/XrGmaopf
Got an idea to improve screening, treatment, or patient care pathway?👉 or9ieqov0cb.typeform.com/to/XrGmaopf
A reminder that gastric cancer can affect anyone, regardless of power or position.
Because most countries don’t offer routine screening, it’s vital that people at high risk know the warning signs.
A reminder that gastric cancer can affect anyone, regardless of power or position.
Because most countries don’t offer routine screening, it’s vital that people at high risk know the warning signs.
The session explored how patent systems can create barriers to the medicines patients need, and equipped advocates with practical knowledge.
Thank you to all the participants!
The session explored how patent systems can create barriers to the medicines patients need, and equipped advocates with practical knowledge.
Thank you to all the participants!
This week, we talked about how biosimilars have helped reshape healthcare . Yet, unequal access remains a major challenge in 🇪🇺 & beyond.
To unlock their full potential, we must work together with policymakers and healthcare professionals #GBSW25
This week, we talked about how biosimilars have helped reshape healthcare . Yet, unequal access remains a major challenge in 🇪🇺 & beyond.
To unlock their full potential, we must work together with policymakers and healthcare professionals #GBSW25
In approximately 5–10% of cases, pancreatic cancer is linked to inherited genetic factors. That’s why knowing your risks is so important!
#PCAM #FamilyHistory
In approximately 5–10% of cases, pancreatic cancer is linked to inherited genetic factors. That’s why knowing your risks is so important!
#PCAM #FamilyHistory
Before approval, each biosimilar undergoes a comprehensive scientific evaluation by the European Medicines Agency to demonstrate equivalence with its reference medicine!
#GBW25
Before approval, each biosimilar undergoes a comprehensive scientific evaluation by the European Medicines Agency to demonstrate equivalence with its reference medicine!
#GBW25
Given that 70–80% of 🇪🇺 healthcare costs are related to chronic conditions, #biosimilars can support by facilitating broader access to treatment & reducing pressure on healthcare systems. #GBW25
Given that 70–80% of 🇪🇺 healthcare costs are related to chronic conditions, #biosimilars can support by facilitating broader access to treatment & reducing pressure on healthcare systems. #GBW25
Take your own #StepsForAction, and help spread the word, because every step counts.
Take your own #StepsForAction, and help spread the word, because every step counts.
This may help healthcare systems become more resilient & patient-focused. #GBW25
This may help healthcare systems become more resilient & patient-focused. #GBW25
Biosimilars have built decades of real-world use, reached patients in 60+ countries & saved 🇪🇺 healthcare systems 💶 €56 billion.
This week, learn more about biosimilars & their benefits➡️ buff.ly/uqOW5LL
Biosimilars have built decades of real-world use, reached patients in 60+ countries & saved 🇪🇺 healthcare systems 💶 €56 billion.
This week, learn more about biosimilars & their benefits➡️ buff.ly/uqOW5LL
Learn more ➡️ buff.ly/5L0PfFB
#GastricCancerAwarenessMonth #GastricCancer #GCAM
Learn more ➡️ buff.ly/5L0PfFB
#GastricCancerAwarenessMonth #GastricCancer #GCAM
During #PACM, we reflect on the stories of well-known people who faced this disease, reminding us that awareness & early action can make all the difference.
During #PACM, we reflect on the stories of well-known people who faced this disease, reminding us that awareness & early action can make all the difference.
At DiCE, we strongly believe that patient participation is not just desirable; it is essential to make research more relevant, inclusive & impactful.
#CancerResearch
At DiCE, we strongly believe that patient participation is not just desirable; it is essential to make research more relevant, inclusive & impactful.
#CancerResearch
#DiCE and #OAC are partnering for a 5K Fun Run & Walk at ESMO GI 2026 in Munich 🇩🇪 this July!
➡️ Sign up now for event updates and early registration: buff.ly/Amm5Im9
📩 funrun@digestivecancers.eu
#DiCE and #OAC are partnering for a 5K Fun Run & Walk at ESMO GI 2026 in Munich 🇩🇪 this July!
➡️ Sign up now for event updates and early registration: buff.ly/Amm5Im9
📩 funrun@digestivecancers.eu
Take a few minutes to complete this survey:
🇬🇧 👉 forms.gle/8kbV4oXu5Sjk...
🇫🇷 👉 forms.gle/84NuHZeesJwE...
🇱🇹 👉 forms.gle/cVPUKxpbY2oA...
🇵🇹 👉 forms.gle/Fh5cycZg9jKe...
🇪🇸 👉 forms.gle/6oAew4CVrGPT...
Take a few minutes to complete this survey:
🇬🇧 👉 forms.gle/8kbV4oXu5Sjk...
🇫🇷 👉 forms.gle/84NuHZeesJwE...
🇱🇹 👉 forms.gle/cVPUKxpbY2oA...
🇵🇹 👉 forms.gle/Fh5cycZg9jKe...
🇪🇸 👉 forms.gle/6oAew4CVrGPT...
@charityammf.bsky.social @easlnews.bsky.social @cholangiocarcinoma.bsky.social @mepsagainstcancer.bsky.social
@charityammf.bsky.social @easlnews.bsky.social @cholangiocarcinoma.bsky.social @mepsagainstcancer.bsky.social